The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress
-
Published:2021-03
Issue:
Volume:501
Page:172-186
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Gleneadie Hannah J.ORCID, Baker Amy H., Batis Nikolaos, Bryant Jennifer, Jiang Yao, Clokie Samuel J.H., Mehanna Hisham, Garcia Paloma, Gendoo Deena M.A.ORCID, Roberts Sally, Burley Megan, Molinolo Alfredo A., Gutkind J. Silvio, Scheven Ben A., Cooper Paul R.ORCID, Parish Joanna L.ORCID, Khanim Farhat L., Wiench MalgorzataORCID
Funder
Medical Research Council
Subject
Cancer Research,Oncology
Reference42 articles.
1. The fundamental role of epigenetic events in cancer;Jones;Nat. Rev. Genet.,2002 2. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine;Stresemann;Int. J. Canc.,2008 3. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses;Chiappinelli;Cell,2015 4. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts;Roulois;Cell,2015 5. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia;Kantarjian;J. Clin. Oncol.,2012
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|